These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

494 related items for PubMed ID: 24928921

  • 1. Fenofibrate vs pioglitazone: Comparative study of the anti-arthritic potencies of PPAR-alpha and PPAR-gamma agonists in rat adjuvant-induced arthritis.
    Koufany M, Jouzeau JY, Moulin D.
    Biomed Mater Eng; 2014; 24(1 Suppl):81-8. PubMed ID: 24928921
    [Abstract] [Full Text] [Related]

  • 2. Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis.
    Koufany M, Moulin D, Bianchi A, Muresan M, Sebillaud S, Netter P, Weryha G, Jouzeau JY.
    Arthritis Res Ther; 2008; 10(1):R6. PubMed ID: 18199331
    [Abstract] [Full Text] [Related]

  • 3. The peroxisome proliferator-activated receptor γ agonist pioglitazone preserves bone microarchitecture in experimental arthritis by reducing the interleukin-17-dependent osteoclastogenic pathway.
    Koufany M, Chappard D, Netter P, Bastien C, Weryha G, Jouzeau JY, Moulin D.
    Arthritis Rheum; 2013 Dec; 65(12):3084-95. PubMed ID: 23982996
    [Abstract] [Full Text] [Related]

  • 4. Combination treatment with pioglitazone and fenofibrate attenuates pioglitazone-mediated acceleration of bone loss in ovariectomized rats.
    Samadfam R, Awori M, Bénardeau A, Bauss F, Sebokova E, Wright M, Smith SY.
    J Endocrinol; 2012 Feb; 212(2):179-86. PubMed ID: 22062085
    [Abstract] [Full Text] [Related]

  • 5. Antinociceptive and antiedematogenic activities of fenofibrate, an agonist of PPAR alpha, and pioglitazone, an agonist of PPAR gamma.
    Oliveira AC, Bertollo CM, Rocha LT, Nascimento EB, Costa KA, Coelho MM.
    Eur J Pharmacol; 2007 Apr 30; 561(1-3):194-201. PubMed ID: 17343847
    [Abstract] [Full Text] [Related]

  • 6. Possible beneficial effect of peroxisome proliferator-activated receptor (PPAR)--α and γ agonist against a rat model of oral dyskinesia.
    Grover S, Kumar P, Singh K, Vikram V, Budhiraja RD.
    Pharmacol Biochem Behav; 2013 Oct 30; 111():17-23. PubMed ID: 23948071
    [Abstract] [Full Text] [Related]

  • 7. Effects of pioglitazone and fenofibrate co-administration on bone biomechanics and histomorphometry in ovariectomized rats.
    Smith SY, Samadfam R, Chouinard L, Awori M, Bénardeau A, Bauss F, Guldberg RE, Sebokova E, Wright MB.
    J Bone Miner Metab; 2015 Nov 30; 33(6):625-41. PubMed ID: 25534548
    [Abstract] [Full Text] [Related]

  • 8. Anti-arthritic and anti-inflammatory activity of combined pioglitazone and prednisolone on adjuvant-induced arthritis.
    Suke SG, Negi H, Mediratta PK, Banerjee BD, Sharma KK.
    Eur J Pharmacol; 2013 Oct 15; 718(1-3):57-62. PubMed ID: 24075936
    [Abstract] [Full Text] [Related]

  • 9. Effects of combined PPAR-γ and PPAR-α agonist therapy on fructose induced NASH in rats: Modulation of gene expression.
    Abd El-Haleim EA, Bahgat AK, Saleh S.
    Eur J Pharmacol; 2016 Feb 15; 773():59-70. PubMed ID: 26825546
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of NF-kappaB signaling by fenofibrate, a peroxisome proliferator-activated receptor-alpha ligand, presents a therapeutic strategy for rheumatoid arthritis.
    Okamoto H, Iwamoto T, Kotake S, Momohara S, Yamanaka H, Kamatani N.
    Clin Exp Rheumatol; 2005 Feb 15; 23(3):323-30. PubMed ID: 15971419
    [Abstract] [Full Text] [Related]

  • 11. Fenofibrate and pioglitazone do not ameliorate the altered vascular reactivity in aorta of isoproterenol-treated rats.
    Fukuda LE, Davel AP, Verissimo-Filho S, Lopes LR, Cachofeiro V, Lahera V, Rossoni LV.
    J Cardiovasc Pharmacol; 2008 Nov 15; 52(5):413-21. PubMed ID: 19033820
    [Abstract] [Full Text] [Related]

  • 12. Effects of peroxisome proliferator-activated receptor (PPAR)-alpha and PPAR-gamma agonists on glucose and lipid metabolism in patients with type 2 diabetes mellitus.
    Bajaj M, Suraamornkul S, Hardies LJ, Glass L, Musi N, DeFronzo RA.
    Diabetologia; 2007 Aug 15; 50(8):1723-31. PubMed ID: 17520238
    [Abstract] [Full Text] [Related]

  • 13. Effects of cevoglitazar, a dual PPARalpha/gamma agonist, on ectopic fat deposition in fatty Zucker rats.
    Laurent D, Gounarides JS, Gao J, Boettcher BR.
    Diabetes Obes Metab; 2009 Jun 15; 11(6):632-6. PubMed ID: 19175377
    [Abstract] [Full Text] [Related]

  • 14. PPAR agonists stimulate adipogenesis at the expense of osteoblast differentiation while inhibiting osteoclast formation and activity.
    Patel JJ, Butters OR, Arnett TR.
    Cell Biochem Funct; 2014 Jun 15; 32(4):368-77. PubMed ID: 24615887
    [Abstract] [Full Text] [Related]

  • 15. A peroxisome proliferator-activated receptor alpha/gamma dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemia.
    Reifel-Miller A, Otto K, Hawkins E, Barr R, Bensch WR, Bull C, Dana S, Klausing K, Martin JA, Rafaeloff-Phail R, Rafizadeh-Montrose C, Rhodes G, Robey R, Rojo I, Rungta D, Snyder D, Wilbur K, Zhang T, Zink R, Warshawsky A, Brozinick JT.
    Mol Endocrinol; 2005 Jun 15; 19(6):1593-605. PubMed ID: 15831517
    [Abstract] [Full Text] [Related]

  • 16. Effect of peroxisome proliferator-activated receptor activators on tumor necrosis factor-alpha expression in neonatal rat cardiac myocytes.
    Ye P, Fang H, Zhou X, He YL, Liu YX.
    Chin Med Sci J; 2004 Dec 15; 19(4):243-7. PubMed ID: 15669179
    [Abstract] [Full Text] [Related]

  • 17. The impact of single and combined PPAR-α and PPAR-γ activation on the neurological outcomes following cerebral ischemia reperfusion.
    Shehata AHF, Ahmed AF, Abdelrehim AB, Heeba GH.
    Life Sci; 2020 Jul 01; 252():117679. PubMed ID: 32325134
    [Abstract] [Full Text] [Related]

  • 18. Comparative transcriptional network modeling of three PPAR-α/γ co-agonists reveals distinct metabolic gene signatures in primary human hepatocytes.
    Deehan R, Maerz-Weiss P, Catlett NL, Steiner G, Wong B, Wright MB, Blander G, Elliston KO, Ladd W, Bobadilla M, Mizrahi J, Haefliger C, Edgar A.
    PLoS One; 2012 Jul 01; 7(4):e35012. PubMed ID: 22514701
    [Abstract] [Full Text] [Related]

  • 19. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications.
    Touyz RM, Schiffrin EL.
    Vascul Pharmacol; 2006 Jul 01; 45(1):19-28. PubMed ID: 16782410
    [Abstract] [Full Text] [Related]

  • 20. Fenofibrate, a PPAR{alpha} agonist, decreases atrogenes and myostatin expression and improves arthritis-induced skeletal muscle atrophy.
    Castillero E, Nieto-Bona MP, Fernández-Galaz C, Martín AI, López-Menduiña M, Granado M, Villanúa MA, López-Calderón A.
    Am J Physiol Endocrinol Metab; 2011 May 01; 300(5):E790-9. PubMed ID: 21304067
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.